Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Annovis Bio Inc (NY: ANVS )

9.795 -0.055 (-0.56%)
Streaming Delayed Price Updated: 2:47 PM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 114,450
Open 9.850
Bid (Size) 9.760 (1)
Ask (Size) 9.830 (3)
Prev. Close 9.850
Today's Range 9.620 - 10.18
52wk Range 5.420 - 22.49
Shares Outstanding 11,011,299
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ANVS Stock Earnings: Annovis Bio Misses EPS for Q4 2023
ANVS stock results show that Annovis Bio missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results
From Annovis Bio Inc.
Via GlobeNewswire

Performance

YTD
-48.26%
-48.26%
1 Month
+9.81%
+9.81%
3 Month
-15.63%
-15.63%
6 Month
+6.47%
+6.47%
1 Year
-33.82%
-33.82%

More News

Read More
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Sportradar Group Posts Upbeat Earnings, Joins Kingsoft Cloud, Braskem And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Sell Signal: 3 Stocks to Unload Before the Bubble Bursts
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
3 Growth Stocks to Sell in February Before They Bottom
Via InvestorPlace
Dow Edges Lower; US Composite PMI Rises In January
Via Benzinga
Topics Stocks
Exposures US Equities
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Rises Over 1%; DuPont Shares Plunge
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Annovis Bio (ANVS) Stock Is Getting Hammered
Via Benzinga
Dow Jumps 100 Points; Netflix Reports Strong Q4 Sales
Via Benzinga
Topics Stocks
Exposures US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
Via MarketBeat
Topics Bonds
Exposures Debt Markets
Annovis Bio Measures Novel Biomarkers in Plasma of Parkinson’s Patients
From Annovis Bio
Via Business Wire
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Why Annovis Bio (ANVS) Stock Hit A New 52-Week Low Today
Via Benzinga
Why Pinterest Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Annovis Bio Announces Pricing of $7.5 Million Public Offering
From Annovis Bio, Inc.
Via Business Wire
Annovis Bio Announces Launch of Proposed Public Offering
From Annovis Bio, Inc.
Via Business Wire
Annovis Bio Receives Positive Recommendation to Continue Phase 2/3 Trial of Buntanetap for Alzheimer’s Disease Patients From the Independent Data and Safety Monitoring Board (DSMB)
From Annovis Bio, Inc.
Via Business Wire
Annovis Bio Showcases Promising Progress in Novel Drug Development at the 2023 Clinical Trials on Alzheimer's Disease Conference
From Annovis Bio, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.